FDA urges rationing in shortage of BD BACTEC blood culture vials While the FDA is required by law to maintain an up-to-date list of medical devices shortages —and manufacturers, in turn ...

The laboratory data included initial blood cell counts ... the processed specimens into MGIT 960 culture tubes according to the manufacturer's instructions (BACTEC Mycobacteria Growth Indicator Tube ...

15 The BACTEC 9120 (BD Diagnostics, Sparks, Maryland, USA) was used for blood cultures. For each positive culture result ... We performed a multivariable analysis to adjust for factors that might be ...

Researchers have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

Greg Rodetis; Senior Vice President, Treasurer and Head of Investor Relations; Becton Dickinson and Co Thomas Polen; Chairman of the Board, President, Chief Executive Officer; Becton Dickinson and ...

Until now, component analysis of culture medium has been carried out by periodic sampling; however, this method only allows for small samples to be collected and requires regular manual sampling, ...

Revenue: US$5.17b (up 9.8% from 1Q 2024). Net income: US$303.0m (up 7.8% from 1Q 2024). Profit margin: 5.9% (down from 6.0% in 1Q 2024). EPS: US$1.05 (up from US$0.97 in 1Q 2024). Revenue exceeded ...

The BD LSRFortessa™ cell analyzer offers the ultimate in choice for flow cytometry, providing power, performance, and consistency. Designed to be affordable and expandable, the BD LSRFortessa ...

American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic solutions arms to become a leaner and more focused company. The news was anno ...

Becton Dickinson BDX1.16%increase; green up pointing triangle and Co. said it plans to break off its bioscience and diagnostic solutions business to focus on medical technology. Chief Executive ...